Skip to main content

Which perspectives for intralesional therapy?

Intervista a Igor Puzanov By 6 Dicembre 2021Dicembre 14th, 2021No Comments
Congressi

Which perspectives for intralesional therapy? We asked Igor Puzanov (Director of Center of Early Phase Clinical Trials – Melanoma Section – Roswell Park Cancer Center, Buffalo), that told us about the evidence about combination immunotherapy using Oncolytic Virus for the treatment of advanced solid tumors during the IMMUNOTHERAPY & MELANOMA BRIDGE Congress 2021.